Nobel Biocare's share price up with takeover speculation, but denies offer
This article was originally published in Clinica
Rumours that private equity firms Bain Capital and EQT Partners are interested in buying dental implant maker Nobel Biocare has sent the latter's stock climbing. The firm's share price on the SIX Swiss Exchange rose by 14% to close at CHF11.38 ($12.92) on 24 October, the day after Swiss newspaper NZZ am Sonntag reported that Bain and EQT were considering making a bid. The share price gives Nobel a total value of CHF1.41bn ($1.6bn).
You may also be interested in...
Israel is well-known as a medtech hot-spot, with a focus on academic research and strong government support helping the country punch well above its weight when it comes to innovative devices.
St Jude Medical had a heavy focus on its intravascular imaging offering at this year’s EuroPCR meeting, presenting data supporting its optical coherence tomography (OCT) technology. OCT provides intravascular images to help assess culprit lesions, which can improve stent selection and deployment, according to St Jude.
A big topic at this year’s EuroPCR, held in Paris on 19-22 May, was drug-coated balloons (DCBs). One of the leaders in the field, Medtronic, presented positive data from two studies of its IN.PACT Admiral balloon, which could support an expanded indication for the device.